Tumor cells across cancer types have been shown to upregulate GLUT1 which, as shown in Figs 1B and 2E, is needed to drive large anabolic fluxes through pathways that use glycolytic intermediates as substrates [62]. Here, SLC2A1 is linked to neoplasm.